RANTES, IFN-γ, CCR1, and CCR5 mRNA expression in peripheral blood, lymph node, and bronchoalveolar lavage mononuclear cells during primary simian immunodeficiency virus infection of macaques

Virology

Volumn 255, Issue 2, 1999, Pages 285-293

  Chéret, Arnaud ^a   Le Grand, Roger ^a   Caufour, Philippe ^a   Neildez, Olivier ^a   Matheux, Franck ^a   Théodoro, Frédéric ^a   Vaslin, Bruno ^a   Dormont, Dominique ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOKINE RELEASE; GENE EXPRESSION; MONKEY; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; TISSUE DISTRIBUTION; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALIA; LENTIVIRUS; MACACA; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0344631687     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9558     Document Type: Article

References (50)

1. Arenzana-Seisdedos F., Virelizier J. L., Rousset D., Clark-Lewis I., Loestscher P., Moser B., Baggiolini M. HIV blocked by chemokine antagonist. Nature. 383:1996;400.
2. Baggiolini M., Dewald B., Moser B. Human chemokines: An update. Annu. Rev. Immunol. 15:1997;675-705.
3. Benveniste O., Vaslin B., Le Grand R., Chéret A., Matheux F., Théodoro F., Cranage M. P., Dormont D. Comparative interleukin (IL)-2/interferon (IFN)-γ and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuatednef. Proc. Natl. Acad. Sci. USA. 93:1996;3658-3663.
4. Berger E. A., Doms R. W., Fenyö E. M., Korber B. T. M., Littman D. R., Moore J. P., Sattentau Q. J., Schuitemaker H., Sodroski J., Weiss R. A. A new classification for HIV-1. Nature. 391:1998;240.
5. Birdsall H. H., Trial J. A., Lin H. J., Green D. M., Sorrentino G. W., Siwak E. B., De Jong A. L., Rossen R. D. Transendothelial migration of lymphocytes from HIV-1-infected donors: A mechanism for extravascular dissemination of HIV-1. J. Immunol. 158:1997;5968-5977.
6. Bleul C. C., Wu L., Hoxie J. A., Springer T. A., Mackay C. R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA. 94:1997;1925-1930.
7. Bonecchi R., Bianchi G., Panina Bordignon P., D'Ambrosio D., Lang R., Borsatti A., Sozzani S., Allavena P., Gray P. A., Mantovani A., Sinigaglia F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:1998;129-134.
8. Chen Z., Zhou P., Ho D. D., Landau N. R., Marx P. A. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71:1997;2705-2714.
9. Chensue S. W., Warmington K., Ruth J. H., Lukacs N., Kunkel S. L. Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-γ and IL-4 knockout mice: Analysis of local and regional cytokine and chemokine network. J. Immunol. 159:1997;3565-3573.
10. Chéret A., Caufour P., Le Grand R., Théodoro F., Boussin F., Vaslin B., Dormont D. Macrophage inflammatory protein-1α mRNA expression in mononuclear cells from different tissues during acute simian immunodeficiency virus strain mac251 infection of macaques. AIDS. 11:1997;257-258.
11. Chéret A., Le Grand R., Caufour P., Dereuddre-Bosquet N., Matheux F., Neildez O., Théodoro F., Maestrali N., Benveniste O., Vaslin B., Dormont D. Cytokine mRNA expression in mononuclear cells from different tissues during acute SIVmac251 infection of macaques. AIDS Res. Hum. Retroviruses. 12:1996;1263-1272.
12. +. Science. 270:1995;1811-1815.
13. Coffey M. J., Woffendin C., Phare S. M., Strieter R. M., Markovitz D. M. RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveoar macrophages. Am. J. Physiol. 272:1997;L1025-L1029.
14. ++. Eur. J. Immunol. 25:1995;751-756.
15. Cossarizza A., Ortolani C., Mussini C., Borghi V., Guaraldi G., Mongiardo N., Bellesia E., Franceshini M. G., De Rienzo B., Franceschi C. Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome. J. Infect. Dis. 172:1995;105-112.
16. Daar E. S., Moudgil T., Meyer R. D., Ho D. D. Transient high levels of viremia in patients with primary human immunodeficiency type 1 infection. N. Engl. J. Med. 324:1991;961-964.
17. Dairaghi D. J., Soo K. S., Oldham E. R., Premack B. A., Kitamura T., Bacon K. B., Schall T. J. RANTES-induced T cell activation correlates with CD3 expression. J. Immunol. 160:1998;426-433.
18. Daniel M. D., Letvin N. L., King N. W., Kannagi M., Sehgal P. K., Kanki P. K., Essex M., Desrosiers R. C. Isolation of a T-cell tropic HTLV-III-like retrovirus from macaques. Science. 228:1985;1200-1204.
19. Desrosiers R. C. The simian immunodeficiency viruses. Annu. Rev. Immunol. 8:1990;557-578.
20. Doms R. W., Peiper S. C. Unwelcomed guests with master keys: How HIV uses chemokine receptors for cellular entry. Virology. 235:1997;179-190.
21. Hadida F., Vieillard V., Autran B., Clark-Lewis I., Bagglioni M., Debré P. HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3. J. Exp. Med. 188:1998;609-614.
22. Hoffman T. L., Doms R. W. Chemokines and receptors in HIV/SIV-host interactions. AIDS. 12:1998;S17-S26.
23. Gerard C., Frossart J. L., Bhatia M., Saluja A., Gerard N. P., Lu B., Steer M. Targeted disruption of the β-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J. Clin. Invest. 100:1997;2022-2027.
24. Lifson J. D., Nowak M. A., Goldstein S., Rossio J. L., Kinter A., Vasquez G., Wiltrout T. A., Brown C., Schneider D., Wahl L., Lloyd A. L., Williams J., Elkins W. R., Fauci A. S., Hirsch V. M. The extend of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J. Virol. 71:1997;9508-9514.
25. Loetscher P., Seitz M., Baggiolini M., Moser B. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184:1996;569-577.
26. Luster A. D. Chemokines - Chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:1998;436-445.
27. Marcon L., Choe H., Martin K. A., Farzan M., Ponath P. D., Wu L., Newman W., Gerard N., Gerard C., Sodroski J. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. J. Virol. 71:1997;2522-2527.
28. Marfaing-Koka A., Devergne O., Gorgone G., Portier A., Schall T. J., Galanaud P., Emilie D. Regulation of the production of the RANTES chemokine by endothelial cells: Synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13. J. Immunol. 154:1995;1870-1878.
29. Matsukura S., Kokubu F., Tomita T., Tokunaga H., Kadokura M., Yamamoto T., Kuroiwa Y., Ohno T., Suzaki H., Adachi M. Expression of RANTES by normal airway epithelial cells after influenza virus A infection. Am. J. Respir. Cell Mol. Biol. 18:1998;255-264.
30. Moriuchi H., Moriuchi M., Fauci A. S. Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. J. Immunol. 159:1997a;5441-5449.
31. Moriuchi H., Moriuchi M., Fauci A. S. Nuclear factor-κB potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 158:1997b;3483-3491.
32. Murphy W. J., Taub D. D., Anver M., Conlon K., Oppenheim J. J., Kelvin D. J., Longo D. L. Human RANTES induces the migration of human T lymphocytes into peripheral tissues of mice with severe combined immune deficiency. Eur. J. Immunol. 94:1994;1823-1827.
33. Ostrowski M. A., Justement S. J., Catanzaro A., Hallahan C. A., Ehler L. A., Mizell S. B., Kumar P. N., Mican J. A., Chun T. W., Fauci A. S. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J. Immunol. 161:1998;3195-3201.
34. Qin S., Rottman J. B., Myers P., Kassam M., Weinblatt M., Loetscher M., Koch A. E., Moser B., Mackay C. R. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:1998;746-754.
35. Reimann K. A., Tenner-Racz K., Racz P., Montefiori D. C., Yasutomi Y., Lin W., Ransil B. J., Letvin N. L. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68:1994;2362-2370.
36. Ringler D. J., Wyand M. S., Walsh D. G., MacKey J. J., Sehgal P. K., Daniel M. D., Desrosiers R. C., King N. W. The productive infection of alveolar macrophages by simian immunodeficiency virus. J. Med. Primatol. 18:1989;217-226.
37. Rosenberg Y. J., Cafaro A., Brennan T., Greenhouse J. G., Villinger F., Ansari A. A., Brown C., McKinnon K., Bellah S., Yalley-Ogunro J., Elkins W. R., Gartner S., Lewis M. G. Virus-induced cytokines regulate circulating lymphocyte levels during primary SIV infections. Int. Immunol. 9:1997;703-712.
38. Rottman J. B., Ganley K. P., Williams K., Wu L., Mackay C. R., Ringler D. J. Cellular localization of the chemokine receptor CCR5: Correlation to cellular targets of HIV-1 infection. Am. J. Pathol. 151:1997;1341-1351.
39. Schall T. J., Bacon K., Toy K. J., Goeddel D. V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 347:1990;669-671.
40. Simmons G., Clapham P. R., Picard L., Offord R. E., Rosenkilde M. M., Schwartz T. W., Buser R., Wells T. N. C., Proudfoot A. E. I. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science. 276:1997;276-279.
41. Su S. B., Mukaida N., Wang J. B., Nomura H., Matsushima K. Preparation of specific polyclonal antibodies to a C-C chemokine receptor, CCR1, and determination of CCR1 expression on various type of leukocytes. J. Leukocyte Biol. 60:1996;658-666.
42. Taub D. D., Ortaldo J. R., Turcovski-Corrales S. M., Key M. L., Longo D. L., Murphy W. J. β chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J. Leukocyte Biol. 59:1996;81-89.
43. Verani A., Scarlatti G., Comar M., Tresoldi E., Polo S., Giacca M., Lusso P., Siccardi A. G., Vercelli D. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J. Exp. Med. 185:1997;805-816.
44. Wagner L., O Yang O., Garcia-Zepeda E. A., Ge Y., Kalams S. A., Walker B. D., Pasternack M. S., Luster A. D. β-Chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature. 391:1998;908-911.
45. Wang Y., Tao L., Mitchell E., Bogers W. M. J. M., Doyle C., Bravery C., Bergmeier L. A., Kelly C. G., Heeney J. L., Lehner T. Generation of CD8 suppressor factor and β chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques. Proc. Natl. Acad. Sci. USA. 95:1998;5223-5228.
46. Weissman D., Rabin R. L., Arthos J., Rubbert A., Dybul M., Swofford R., Venkatesan S., Farber J. M., Fauci A. S. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature. 389:1997;981-985.
47. Wu L., LaRosa G., Kassam N., Gordon C. J., Heath H., Ruffing N., Chen H., Humblias J., Samson M., Parmentier M., Moore J. P., Mackay C. R. Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 186:1997a;1373-1381.
48. Wu L., Paxton W. A., Kassam N., Ruffing N., Rottman J. B., Sullivan N., Choe H., Sodrosky J., Newman W., Koup R. A., Mackay C. R. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185:1997b;1681-1691.
49. Yang A. G., Bai X., Huang X. F., Yao C., Chen S. Y. Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection. Proc. Natl. Acad. Sci. USA. 94:1997;11567-11572.
50. Zou W., Lackner A. A., Simon M., Durand-Gasselin I., Galanaud P., Desrosiers R. C., Emilie D. Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J. Virol. 71:1997;1227-1236.